Development of an oral suspension containing dry extract of Aleurites moluccanus with anti-inflammatory activity


Aleurites moluccanus L. (Willd.), Euphorbiaceae, is a tree that is native to Indonesia and India. Various parts of this tree are commonly used in traditional medicine to treat pain, fever, inflammation, hepatitis, gastric ulcer and other ailments. An oral suspension containing dried extract of A moluccanus was developed and in vivo anti-inflammatory activity was evaluated. Extract 100 and 50mg/ml loaded oral suspensions were prepared using different suspending agents. The formulations were analysed by their appearance, pH, density, redispersion time, rate of settling, Theological behaviour, distribution of particle size and zeta potential. The dose uniformity was determined by measuring the content of total phenolic compounds expressed in swertisin by a validated HPLC method, as well as the dissolution profile. The stability of oral suspensions was analysed in accelerated studies (40 °C for 6 months). The anti-inflammatory activity was analysed using an in vivo paw oedema model. The taste and odour of the suspensions were shown to be characteristic of the extract. Carmellose sodium (CS; 0.5%) and microcrystalline cellulose and carmellose sodium mixture (MCCS; 1%) showed better physical behaviour. The content of total phenolic compounds was 1.6 mg/ml and approximately 100% of the total phenolic compounds dissolved within 10 min. During the stability study, the formulations were approved by their physical-chemical properties and were shown to lose 12–14% of total phenolic compounds at 40 °C after 6 months. Suspensions containing 50mg/ml of standardised dried extract inhibited around 35 ± 7.6% of paw oedema. Formulations containing CS showed more anti-inflammatory activity. Suspensions containing dry extract of A. moluccanus were successfully obtained and showed physical and physical-chemistry properties that were appropriate and characteristic of this dosage form, suitable for administration in paediatric and elderly populations, making this an alternative to tablets.


  1. Anvisa, 2003. RE no 899, de 29 de maio de 2003. Guia para validação de métodos analíticos e bioanalíticos. Brasília.

    Google Scholar 

  2. Anvisa. 2005. RE n° 1, de 29 de julho de 2005. Dispém sobre o guia para a realização de estudos de estabilidade. Brasília.

    Google Scholar 

  3. Anvisa, 2012. RDC n° 27, de 17 de maio de 2012. Dispõe sobre os requisites mínimos para a validação de métodos bioanalíticos. Brasília.

    Google Scholar 

  4. AOAC, 2012. Guidelines for Single Laboratory Validation of Chemical Methods for Dietary Supplements and Botanicals.19 dez.2012.

    Google Scholar 

  5. British Pharmacopoeia, 2008. 5th ed. London: The Stationery Office, v. 3.

  6. Cesca, G.T., Block, L.C., Machado, M.S., Wittkowski, C., Meyre-Silva, C., Souza, M.M., Quintao, N.L., Silva, R.L., Silva, D.B., Fernandes, E., Ferreira, L.S., Lopes, N.P., Cechinel-Filho, V., Bresolin, T.M.B., 2012a. Validation of the stability-indicating HPLC method for the major flavonoids in spray-dried leaf extract of Aleuntes moluccana L. Willd. Curr. Pharm. Anal. 8, 1–11.

    Article  Google Scholar 

  7. Cesca, T.G., Faqueti, L.G., Rocha, L.W., Meira, N.A., Meyre-Silva, C., Souza, M.M., Quintao, N.L.M., Silva, R.M.L., Cechinel-Filho, V., Bresolin, T.M.B., 2012b. Antinociceptive, anti-inflammatory and wound healing features in animal models treated with a semisolid herbal medicine based on Aleuntes moluccana L Willd. Euforbiaceae standardized leaf extract: semisolid herbal medicine based on Aleuntes moluccanna L Willd. Euforbiaceae standardized leaf extract. J. Ethnopharmacol. 143, 355–362.

    CAS  Article  PubMed  Google Scholar 

  8. Duke, A., 1991. Handbook of Medicinal Herbs. CRC Press, USA.

    Google Scholar 

  9. Dunfors, B., Andrews, L., Ayau, M., Honda, L.I., Williams, J.S., 2002. Hawaiians of Old, 3th ed. [S.1.]: Bess Press.

    Google Scholar 

  10. EMA. EMEA/CHMP/PEG/194810/2005, 2006. Reflection Paper: Formulations of Choice for the Paediatric Population. London.

    Google Scholar 

  11. Farmacopeia Brasileira, 2010. 5. ed. Agênda Nacional de VigilãnciaSanitária, Brasilia.

    Google Scholar 

  12. Florence, A.T., Attwood, D., 2006. Physicochemical Principles of Pharmacy, 4th ed. Pharmaceutical Press, Grayslake.

    Google Scholar 

  13. ICH, 2005. Quality Guideline Validation of Analytical Procedures: Text and Methodology Q2(R1). Genebra.

    Google Scholar 

  14. Martin, A.N., 2006. Coarse dispersions. In: Sinko, P.J. (Ed.), Martin’s Physical Pharmacy and Pharmaceutical Sciences., 5th ed. Lippincott Williams & Wilkins, Philadelphia.

    Google Scholar 

  15. Meyre-Silva, C.M., Mora, T.C., Santos, A.R.S., Dal Magro, J., Yunes, R.A., Delle Monache, F., Cechinel Filho, V., 1997. Atriterpene and a flavonoid C-glycoside from Aleuntes moluccana L. (Willd.) (Euphorbiaceae). Acta Farm. Bonaerense 16, 169–172.

    CAS  Google Scholar 

  16. Meyre-Silva, C., Mora, T.C., Santos, A.R.S., Dal Magro, J., Yunes, R.A., Cechinel-Filho, V., 1998. Preliminary phytochemical and pharmacological studies of Aleuntes moluccana leaves (L.) Willd. Phytomedicine 5, 109–113.

    CAS  Article  PubMed  Google Scholar 

  17. Meyre-Silva, C., Mora, T.C., Santos, A.R.S., Dal Magro, J., Yunes, R.A., Cechinel Filho, V., 1999. Isolation of a c-glycoside flavonoid with antinociceptive action from Aleuntes moluccana leaves. Planta Med. 65, 293–294.

    CAS  Article  PubMed  Google Scholar 

  18. Nutan, M.T.H., Reddy, Lit, 2010. General principles of suspensions. In: Kulshreshtha, A.K., Singh, O.N., Wall, G.M. (Eds.), Pharmaceutical Suspensions from Formulation Development to Manufacturing. Springer, New York.

    Google Scholar 

  19. Quintao, N.L.M., Meyre-Silva, C., Silva, G.F., Antonialli, C.S., Rocha, L.W., Lucinca-Silva, R.M., Malheiros, A., Souza, M.M., Cechinel Filho, V., Bresolin, T.M.B., 2011. Aleuntes moluccana (L) Willd leaves: mechanical antinociceptive properties of a standardized dried extract and its chemical markers. Evid. Based Compl. Alt., 10.

  20. Quintão, N.L., Antonialli, C.S., Silva, G.S., Rocha, L.W., Souza, M.M., Malheiros, A., Meyre-Silva, C., Lucinda-Silva, R.M., Bresolin, T.M., Cechinel Filho, V., 2012. Aleurites moluccana and its main active ingredient, the flavonoid 2-0-rhamnosylswertisin, have promising antinociceptive effects in experimental models of hypersensitivity in mice. Pharmacol. Biochem. Behav. 102, 302–311.

    Article  PubMed  Google Scholar 

  21. Silva, D.B., Fernandes, E.F.A., Ferreira, L.S., Callejon, D.R., Guaratini, T., Lopes, J.N.C., Meyre-Silva, C., Cechinel Filho, V., Lopes, N.P., 2012. Megastigmanes from Aleuntes moluccana (L.) Willd. (Euphorbiaceae). Biochem. Syst. Ecol. 40, 34–37.

    Article  Google Scholar 

  22. Tagliari, M.P., Stulzer, H.K., Assreuy, J., Bresolin, M.B., Silva, M.A.S., 2009. Evaluation of physicochemical characteristics of suspensions containing hydrochlorothiazide developed for pediatric use. Lat. Am. J. Pharm. 28, 734–740.

    CAS  Google Scholar 

  23. Tratsk, K.S., Campos, M.M., Vaz, Z.R., Cechinel Filho, V., Schlemper, V., Yunes, R.A., Calixto, J.B., 1997. Anti-allergic effects and oedema inhibition caused by the extract of Drymis winen. Inflamm. Res. 46, 509–514.

    CAS  Google Scholar 

  24. The United States Pharmacopoeia, 2012. The National Formulary, 35th ed. NF 30. Rockwille:United States Pharmacopeial Convention.

    Google Scholar 

Download references


The authors wish to thank the Laboratório Farmacêutico Eurofarma (São Paulo, Brazil), FINEP/MCT (Financiadora de Estudos e Projetos/Ministério da Ciência e Tecnologia) (no. 01.05.0812.00), Fundação de Amparo a Pesquisa e Inovação no Estado de Santa Catarina, CNPq, MS/DECIT (Ministério da Saúde/Departamento de Ciência e Tecnologia da Secretaria de Ciência, Tecnologia e Insumos Estratégicos), CT-BIOTEC (Fundos Setoriais de Biotecnologia) and CT-Saúde (Fundos Setoriais de Saúde, Edital Bioinova No. 551023/2007-4) for their financial support during this study. RMD is M.Sc. students in Pharmaceutical Science supported by grants from the Eurofarma/Univali.

Author information




RMD and SSC carried out the laboratory work, data analysis and writing of the manuscript. NLMQ supervised the pharmacological studies and contributed to critical writing and reading of the manuscript. CMS and VCF contributed to botanical, phytochemistry and analytical studies. TMBB and RMLS contributed to designed the study, supervised the analytical and technological studies and contributed to critical writing and reading of the manuscript. All the authors have read the final manuscript and approved the submission.

Corresponding author

Correspondence to Ruth Meri Lucinda-Silva.

Ethics declarations

The authors declare no conflicts of interest.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mac Donald, R., Camargo, S.S., Meyre-Silva, C. et al. Development of an oral suspension containing dry extract of Aleurites moluccanus with anti-inflammatory activity. Rev. Bras. Farmacogn. 26, 68–76 (2016).

Download citation


  • Aleurites moluccanus
  • Anti-inflammatory
  • Phytomedicine
  • Oral suspension